> ## Content Index
> Fetch the complete content index at: https://newsanek.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Indian scientist shows at-home breast cancer screening technology at Moscow symposium
- URL: https://newsanek.com/niramai-at-home-breast-cancer-screening-moscow/
- Published: 2026-11-16T10:32:32.000Z
- Updated: 2026-11-16T10:50:39.000Z
- Description: Geetha Manjunath, founder of Niramai Health Analytix, presented her Thermalytix technology in Moscow. It uses thermal imaging and AI, and needs no radiation or compression. Only one to two percent of Indian women get regular screening.
- Author: Kumar Ujjwal
- Tags: Startups, UPSC Today, GS Paper 3, #sub-startup-stories, #sub-business-stories, #sub-science-space, #national-desk, #sm-58, #smemo-useful

Geetha Manjunath is the founder and CEO of Niramai Health Analytix. She is an Indian scientist.

Recently, she presented her at-home breast cancer screening technology at a symposium in Moscow, Russia.

The technology is called Thermalytix. It is designed to let women check for breast cancer at home.

### Key points

- Geetha Manjunath presented Thermalytix at a Moscow symposium.
- It uses thermal imaging and AI, with no radiation or compression.
- Only one to two percent of women in India get regular screening.
- The symposium drew over 8,000 participants from 109 countries.

## So how does this technology work?

Thermalytix uses thermal imaging and artificial intelligence. Thermal imaging reads heat given off by the body.

The test uses no radiation and no compression. That makes it an alternative to traditional screening methods.

## So why does this matter for India?

Only one to two percent of women in India get regular screening. That is a very low number.

Breast Cancer Screening in India

**1-2%**Women in India getting regular screening

**8,000+**Participants at the Moscow symposium

**109**Countries represented

Graphic: News Anek, from the facts in this report

Late diagnosis is a major factor behind high breast cancer death rates in India.

Her startup wants to make screening available even in homes.

## What else happened at the symposium?

Manjunath was the only speaker from India at the symposium. She said it was a great honour to represent her country there.

Over 8,000 participants from 109 countries attended. Russian President Vladimir Putin sent greetings.

Maxim Oreshkin, a Russian economist, officially opened the event.

The event also included a gaming project called 'Gaming Session of the Future'.

It came at a time when India's gaming market is growing fast.

## What does she hope comes next?

Manjunath hopes for collaboration between Russia and India in science and cultural exchange.

The report does not give details of any specific next steps.

Startup Story

### The story so far

1. **The founder:** Geetha Manjunath is the founder and CEO of Niramai Health Analytix.
2. **The idea:** The startup aims to make breast cancer screening available even in homes.
3. **Now:** Manjunath presented its Thermalytix technology at a symposium in Moscow.

### One lesson

Pick a problem many people face, and show clearly how your product solves it safely.

### The numbers

| Participants at the symposium  | over 8,000 (Source: Symposium report) |
| ------------------------------ | ------------------------------------- |
| Countries sending participants | 109 (Source: Symposium report)        |

This is general information from news reports, not financial or investment advice.

Exam Corner

**UPSC GS Paper 3** · Science and Tech: Health technology

### What's the news

Indian scientist Geetha Manjunath presented her at-home breast cancer screening technology, Thermalytix, at a symposium in Moscow, Russia.

### Background

- Thermalytix uses thermal imaging and artificial intelligence, with no radiation or compression.
- Only one to two percent of women in India undergo regular breast cancer screening.
- Late diagnosis is a major factor in high breast cancer mortality rates in India.

### Facts for Prelims

- Thermalytix is an at-home breast cancer screening technology.
- The 'Inventing the Future' Symposium was held in Moscow.
- Maxim Oreshkin, a Russian economist, officially opened the symposium.

### Content for Mains

1. **Significance:** Early screening can help detect disease sooner, and home tools may widen access.
2. **Main issue:** Regular screening among Indian women is very low despite high mortality rates.
3. **Challenges:** New health technologies need careful validation, trust and reach across the country.
4. **Way forward:** Affordable home tools must work alongside awareness and public health services.

**Practice question:** Discuss how technology-based screening can help reduce late diagnosis of breast cancer in India.

### Prelims practice questions

**Q1.** Which technology does Thermalytix use?

1. X-ray imaging alone
2. Thermal imaging and artificial intelligence
3. Genetic testing
4. Ultrasound scanning
Show answer

**Answer: B.** The article says Thermalytix uses thermal imaging and artificial intelligence.

**Q2.** How many countries did participants at the Moscow symposium come from?

1. 52
2. 84
3. 109
4. 170
Show answer

**Answer: C.** The article says the symposium drew over 8,000 participants from 109 countries.

### Key terms

- **Thermal imaging**: A way of creating images from the heat given off by a body.
- **Artificial intelligence, or AI**: Computer systems that learn patterns from data and help make decisions.
- **Screening**: Checking people for a disease before its symptoms become serious.

More stories for exam preparation: [UPSC Today](https://newsanek.com/upsc-today/)

These points come from this news report. Check them with standard sources such as NCERT books and PIB before your exam.

---

### Sources

- [Lokmat Times: Indian Scientist Geetha Manjunath Showcases At-Home Breast Cancer Screening at Moscow Symposium](https://www.lokmattimes.com/business/indian-scientist-geetha-manjunath-showcases-at-home-breast-cancer-screening-at-moscow-symposium-a001-w01/?ref=newsanek.com)